<description>&lt;p&gt;In this episode, we explore when and why long-acting injectable antipsychotics (LAIs) should be considered for patients with schizophrenia, covering approved indications, ideal candidate profiles, and the critical role of shared decision-making in treatment planning.&lt;/p&gt; &lt;p&gt;Faculty: Brian Miller, M.D., Ph.D., M.P.H.&lt;br /&gt; Host: Richard Seeber, M.D.&lt;/p&gt; &lt;ul&gt; &lt;li&gt;&lt;a href= "https://psychopharmacologyinstitute.com/cme-program?section=pricing&amp;utm_source=Podcast&amp;utm_medium=Podcast&amp;utm_campaign=[Libsyn]OPC456" target="_blank" rel="noopener"&gt;&lt;strong&gt;Learn more about our memberships here&lt;/strong&gt;&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://psychopharmacologyinstitute.com/section/the-role-of-long-acting-injectable-antipsychotics-in-schizophrenia-treatment-2881-5882/?utm_source=Podcast&amp;utm_medium=Podcast&amp;utm_campaign=[Libsyn]OPC456" target="_blank" rel="noopener"&gt;&lt;strong&gt;Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia&lt;/strong&gt;&lt;/a&gt;&lt;/li&gt; &lt;li&gt;&lt;a href= "https://psychopharmacologyinstitute.com/section/understanding-when-to-prescribe-lais-2881-5883/?utm_source=Podcast&amp;utm_medium=Podcast&amp;utm_campaign=[Libsyn]OPC456" target="_blank" rel="noopener"&gt;&lt;strong&gt;Understanding When to Prescribe LAIs&lt;/strong&gt;&lt;/a&gt;&lt;/li&gt; &lt;/ul&gt;</description>

Psychopharmacology and Psychiatry Updates

Psychopharmacology Institute

Preventing Relapse: The Role of LAIs in Schizophrenia

JUN 5, 20267 MIN
Psychopharmacology and Psychiatry Updates

Preventing Relapse: The Role of LAIs in Schizophrenia

JUN 5, 20267 MIN

Description

In this episode, we explore when and why long-acting injectable antipsychotics (LAIs) should be considered for patients with schizophrenia, covering approved indications, ideal candidate profiles, and the critical role of shared decision-making in treatment planning. Faculty: Brian Miller, M.D., Ph.D., M.P.H. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.75 CME: Use of Long-Acting Injectable Antipsychotics in Schizophrenia Understanding When to Prescribe LAIs